CSL-689

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameCSL-689
Drug Alias NamerVIIa-FPCSL-689
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factorBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionCoagulation factor IX stimulantsCoagulation factor X stimulantsBlood coagulation pathway activation +[4] 
TargetsCoagulation factor IXCoagulation factor X
Therapy Area/IndicationsHemophilia BHemophilia AFactor VII Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUkraineThailandNetherlands +[12] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCsl Behring
Active IndicationsN/A
Inactive IndicationsHemophilia BHemophilia AFactor VII Deficiency

Other Information

ATC CodeN/A
Related LinksN/A